IIBA Announces The Business Analysis Standard

IIBA’s Business Analysis Standard is a new resource developed with input from the global business analysis community to address current practice needs

TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — The International Institute of Business Analysis™ (IIBA®) is the global association leading the business analysis community and professional standards, so every person achieves more. IIBA® is excited to announce the release of The Business Analysis Standard, a new publication that provides a simplified, inclusive view of business analysis, including foundational concepts that have been curated from our global business analysis community. The Business Analysis Standard replaces The Global Business Analysis Core Standard and provides a refreshed view of the foundational concepts of business analysis.

This new publication has been developed to provide greater depth and understanding to the evolving business analysis profession. The Business Analysis Standard incorporates an ease-of-use format for concepts and principles, a guide to principal knowledge resources and a comprehensive starting point for the business analysis community. 57% of business analysis professionals report their organization uses non-standard business analysis practices (Global State of Business Analysis Report, 2021). This highlights the opportunity for broader acceptance of established business analysis tasks, techniques, and practices to produce better business outcomes.

The Business Analysis Standard was created as a response to a need from our global community and is the heart of the foundation for good business analysis. It not only emphasises the importance of mindset for good business analysis but is a pathway for anyone wanting to implement these globally accepted foundational standards into their own work. As we did with the Core Standard, IIBA will make this valuable resource available to everyone,” says Delvin Fletcher, President and CEO, IIBA.

The new, innovative Business Analysis Standard was created using a multi-stakeholder process with several engaged groups of globally sourced volunteers representing various industries and levels of expertise within the global business analysis community. To stay ahead of changing practitioner needs, this higher-value standard has been established collaboratively to represent modern business analysis practices and help professionals successfully connect effective analysis to business results. The Business Analysis Standard will not impact current IIBA certification exam requirements or existing course materials.

New material found in The Business Analysis Standard includes:

  • Summarized foundational information
  • Information about the mindset required to focus on value creation
  • Integration of agile business analysis to address hybrid approaches
  • Addition of business analysis task cards for better real-world application

For more information and a complimentary copy of The Business Analysis Standard please visit www.iiba.org/TheStandard.

About IIBA

International Institute of Business Analysis™ (IIBA®) is a professional association dedicated to supporting business analysis professionals to deliver better business outcomes. IIBA connects 30,000 Members, over 100 Chapters, and more than 500 training, academic, and enterprise partners around the world. As the global voice of the business analysis community, IIBA supports recognition of the profession, networking and community engagement, standards and resource development, and comprehensive certification programs. For more information, visit iiba.org.

Shyra Wells, Communications & Media Specialist, IIBA
(289) 212-3657 – Shyra.Wells@iiba.org

GlobeNewswire Distribution ID 8705480″

Kiteworks Releases Its 2023 Forecast for Managing Private Content Exposure Risk Report

15 predictions on data privacy and compliance that provide guidance to IT, security, risk, and compliance leaders in 2023

PALO ALTO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Kiteworks, which delivers data privacy and compliance for sensitive content communications through its Private Content Network, released its 2023 Forecast for Managing Private Content Exposure Risk Report that reveals 15 predictions for private content and sensitive content communications based on cybercrime, cybersecurity, and compliance insights.

Managing private content exposure risk is a crucial priority today—and one that is growing in scope. Organizations must have comprehensive security and compliance capabilities in place to protect the sends, shares, receives, and stores of sensitive content. They must also demonstrate compliance with robust security frameworks and standards, such as SOC 2, the National Institute of Standards and Technology (NIST) Cybersecurity Framework (CSF), and ISO 27001, as well as governmental and industry regulations, such as the Cybersecurity Maturity Model Certification (CMMC 2.0), Federal Information Processing Standard (FIPS 140-2), and General Data Protection Regulation (GDPR).

Managing private content exposure risk poses a significant undertaking for IT, security, risk, and compliance leaders. “Our team meets with thousands of private and public sector organizations during the year, and the 15 cybercrime, cybersecurity, and compliance areas we identified in the report will play an increasingly important role in how organizations manage risk in 2023,” said Yaron Galant, Chief Product Officer at Kiteworks. “As the exchange of private digital data becomes more ubiquitous and bad actors embrace attack vectors that are increasingly advanced and complex, the risk of data theft, ransomware attacks, and compliance violations grows. In response, organizations require a content-defined zero-trust approach that protects private data while demonstrating compliance with cybersecurity frameworks and standards and data privacy regulations.”

Some notable trends in the 2023 Forecast Report include:

  • Organizations increasingly recognize multitenant cloud hosting provides cyberattackers with fertile ground for pinpointing software vulnerabilities, developing complex exploits, and ultimately intercepting sensitive content moving through the software supply chain.
  • Content-defined zero trust is becoming the standard for businesses to protect their unstructured data, using policy-driven tracking and controls, from cybercriminals and rogue nation-states.
  • Organizations storing private content in the public cloud, and therefore only co-managing their encryption keys, will increasingly seek out private cloud alternatives to mitigate snooping by law enforcement and security agencies.
  • Artificial intelligence (AI), used to detect anomalous data shares and transfers, will see broader adoption by organizations looking to better govern and protect their sensitive content.
  • Risk management professionals will further embrace adding layers of security that make it harder for bad actors to infiltrate networks and exfiltrate sensitive content.

To learn more about these and the remaining data exposure risk forecasts for 2023, IT, security, risk, and compliance leaders can access the report and other content related to it, including register for a webinar panel discussion, here.

About Kiteworks

Kiteworks’ mission is to empower organizations to effectively manage risk in every send, share, receive, and save of sensitive content. The Kiteworks platform provides customers with a Private Content Network that delivers content governance, compliance, and protection. The platform unifies, tracks, controls, and secures sensitive content moving within, into, and out of their organization, significantly improving risk management and ensuring regulatory compliance on all sensitive content communications.

Media Contact

Patrick Spencer
VP of Corporate Marketing

GlobeNewswire Distribution ID 8705637

Aqualia Selects Cority Safety Essentials Solution

Leading European water management company seeks to bolster global health and safety program with integrated digital solution

Cority logo

Cority logo

TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) — Global enterprise EHS (Environmental, Health, and Safety) software provider Cority announced today its partnership with a new customer, Aqualia, a leading global water management company. The Spain-based organization, owned by the citizen services group FCC (51%) and by the Australian ethical fund IFM Investors (49%) sought a simplified, integrated digital solution to manage its worldwide health and safety program across its expansive network and selected Cority’s Safety Essentials.

“We were looking for a solution to manage our global Health & Safety program,” said Pascual Capmany, director of health & wellbeing at Aqualia. “Our goal was to bring increased visibility and control over our safety management initiatives and felt Cority had the ideal solution. Choosing Cority, a global leader in EHS software, demonstrates our absolute commitment to the health, safety, and well-being of our people – our greatest asset.”

Aqualia is one of the largest water management companies across the globe. Serving 43.5 million consumers in 17 countries, the company is one of the leaders in the water management industry and all stages of the end-to-end water cycle.

Looking for a global solution to classify and categorize safety information, Aqualia aims to enhance visibility and gain actionable insights to prevent incidents and near misses. Cority’s Safety Essentials offers simplicity and rapid deployment along with its ability to grow and scale. Like all Cority Essentials solutions, Safety Essentials enables rapid time-to-value, deploying in just weeks. With built-in best practices, out-of-the-box reports and analytics, an intuitive interface, and simplified data collection, it enables organizations to quickly establish a solid foundation for their safety programs.

“Cority offers the best-in-class integrated technology coupled with its ease of use, and the simplicity of the dashboards and reporting. This will empower our employees to focus on assessing and managing risk effectively rather than spending time on administrative tasks,” added Capmany.

Features of the Safety Essentials solution that will provide immediate value to Aqualia’s programs include incident safety observation and investigation management, root cause analysis, corrective actions (CAPPA), and reporting with robust dashboard capabilities. As part of its strategic vision to standardize and simplify incident reporting and mitigation, Aqualia is also deploying Cority’s mobile application, myCority, to capture data points straight from the field and empower its workforce to play an integral role in the company’s health and safety management program.

Safety Essentials is available as a stand-alone solution or as part of CorityOne™, the company’s responsible business platform, consisting of a comprehensive suite of solutions for managing environmental, health, safety, sustainability, and quality programs.

“We welcome Aqualia to our expanding Spanish customer base which includes Airbus and several leading manufacturing companies in the region,” said Tjeerd Hendel-Blackford, head of international sales for Cority. “We’re thrilled to support the organization’s strategic vision to streamline workflows and reduce incident rates, furthering their commitment to invest in their people, advancing responsible business practices, and embracing digitalization.”

Media Contact: Meredith Schweitzer//mschweitzer@66and.co//347-698-9196

About Cority

Cority gives every employee from the field to the boardroom the power to make a difference, reducing risks and creating a safer, healthier, and more sustainable world. For over 35 years, Cority’s people-first software solutions have been built by EHS and sustainability experts who know the pressures businesses face. Time-tested, scalable, and configurable, CorityOne is the responsible business platform that combines datasets from across the organization to enable improved efficiencies, actionable insights, data-driven decisions, and more accurate reporting on performance. Trusted by more than 1,300 organizations worldwide, Cority deeply cares about helping people work toward a better future for everyone. To learn more, visit www.cority.com.

About Aqualia 

Aqualia is the 4th largest water company in Europe by population served and the 9th largest in the world, according to the Global Water Intelligence ranking (March 2021). It serves 43.5 million users and promotes long-term projects in 17 countries: Algeria, Saudi Arabia, Colombia, Chile, Peru, Egypt, Arab Emirates, Spain, France, Italy, Mexico, Oman, Portugal, Qatar, Czech Republic, Romania and Georgia.  The company is considered a benchmark brand in the sector, positioned as cutting-edge, specialised, transparent and innovative. Thanks to a committed team, with great experience, which constantly seeks to improve efficiency in production processes and optimisation of resources and with a clear orientation towards the citizen. More info: www.aqualia.com

Contact Information:
Meredith Schweitzer

Related Images

Image 1: Cority logo

This content was issued through the press release distribution service at Newswire.com.


GlobeNewswire Distribution ID 8705179

AUM Biosciences Receives FDA Orphan Drug Designation for AUM302 for the Treatment of Neuroblastoma

AUM302 has potential to be the first multi-kinase inhibitor class of drug in Neuroblastoma

SINGAPORE and BETHESDA, Md., Nov. 30, 2022 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced today that the U.S. Food and Drug Administration (“FDA”) has granted Orphan Drug Designation for AUM302, a potential first-in-class oral kinase inhibitor that targets not only PI3K, but also key resistance mechanisms such as PIM and mTOR, for the treatment of neuroblastoma.

“The Orphan Drug Designation for AUM302 is the second Orphan Drug Designation we have received for our products this year, marking a significant milestone for AUM as we advance our diverse pipeline of precision oncology therapeutics designed to reverse cancer resistance,” said Vishal Doshi, Founder and CEO of AUM. “AUM302 has the potential to be the first-in-class multi-kinase inhibitor for treatment of neuroblastoma. The FDA decision reinforces the strength of our drug development strategy and clinical trial design to deliver affordable, safe, and effective oncology treatments.”

Preclinical studies of AUM302 have indicated that complementing conventional chemotherapy treatment with PIM/PI3K/mTOR inhibition has the potential to improve clinical outcomes in children with high-risk neuroblastoma as well as inhibit cancer cell growth, and prevent resistance emergence.

“Despite progress in understanding drug resistance over the last decade, knowledge gaps remain about the underlying biological causes of drug resistance and the design of cancer treatments to overcome it,” continued Mr. Doshi. “Our goal is to reverse cancer resistance with a broad portfolio of cost-effective therapies.”

Orphan Drug Designation status is granted by the FDA’s Office of Orphan Products Development to drug and biologic candidates that are intended for the treatment, diagnosis or prevention of rare diseases, meaning conditions that affect fewer than 200,000 people in the U.S. Orphan Drug Designation provides certain benefits, including financial incentives, to support clinical development and the potential for up to seven years of market exclusivity for the drug for the designated orphan indication in the U.S. if the drug is ultimately approved for its designated indication.

On October 20, 2022, AUM and Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) (“Mountain Crest”), a publicly traded special purpose acquisition company formed in Delaware, whose management team has an impressive pedigree of successful SPAC transactions, announced that they have entered into a definitive business combination agreement (the “Agreement”). Upon closing of the transaction, the combined company will operate under a holding entity, AUM Biosciences Limited, a Cayman Islands exempted company (“Holdco”), and intends to trade on the Nasdaq Stock Market under the ticker symbol AUMB.

About AUM302
AUM302 is a potential first-in-class oral kinase inhibitor rationally designed to uniquely combine pan-PIM kinase, pan-PI3K and mTOR inhibition in a single agent. This multi-targeting approach has been engineered into a single molecule that has the potential to inhibit multiple key intracellular pathways, increasing its ability to inhibit cancer cell growth and prevent resistance emergence. In early studies to date, AUM302 has shown promise with good tolerability and favourable drug properties. AUM302 is a unique multi-targeted cancer therapeutic that targets not only PI3K, but also key resistance mechanisms such as PIM and mTOR. AUM302 is a single molecule therapeutic designed to optimize inhibition of these key pathways.

About AUM Biosciences
AUM is a global clinical-stage oncology company focused on advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance. AUM is advancing a broad portfolio of precision oncology therapeutics. AUM001 is a selective and synergistic MNK inhibitor as shown in current studies and expected to begin Phase 2 enrolment in the fourth quarter 2022. AUM601 is a promising therapy for tropomyosin receptor kinase (TRK) fusions and mutations within the kinase domain and is on track to enter Phase 2 planning. AUM302 is a potentially first-in-class macrocyclic oral kinase inhibitor rationally designed small molecule to uniquely combine pan-PIM kinase, pan-PI3K and mTOR inhibition in a single agent. Comprised of industry veterans with decades of research and development experience, the AUM leadership has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and has contributed to over 50 INDs and over 150 oncology clinical trials, and development of several currently marketed oncology treatments with annual peak sales up to $3 billion.

About Mountain Crest
Mountain Crest Acquisition Corp. V (Nasdaq: MCAG) is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

This press release shall not constitute a solicitation of a proxy, consent, or authorization with respect to any securities or in respect of the proposed business combination. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.

Important Information About the Proposed Business Combination and Where to Find It
In connection with the proposed business combination, AUM, Mountain Crest and/or a successor entity of the transaction intends to file relevant materials with the SEC, including a registration statement on Form F-4 containing a proxy statement/prospectus (the “Registration Statement”). The Registration Statement will include a proxy statement/prospectus to be distributed to holders of Mountain Crest’s common stock in connection with Mountain Crest’s solicitation of proxies for the vote by Mountain Crest’s stockholders with respect to the proposed transaction and other matters as described in the Registration Statement, as well as the prospectus relating to the offer of securities to be issued to AUM’s stockholders in connection with the proposed business combination. After the Registration Statement has been filed and declared effective, Mountain Crest will mail a definitive proxy statement, when available, to its stockholders. Copies of these documents may be obtained free of charge at the SEC’s website at www.sec.gov. Stockholders of Mountain Crest are urged to read the Registration Statement and the other relevant materials when they become available before making any voting decision with respect to the proposed business combination because they will contain important information. The information contained on, or that may be accessed through, the website referenced in this press release is not incorporated by reference into, and is not a part of, this press release.

Participants in the Solicitation
Mountain Crest and its directors and executive officers may be deemed participants in the solicitation of proxies from Mountain Crest’s stockholders with respect to the business combination. A list of the names of those directors and executive officers and a description of their interests in Mountain Crest will be included in the Registration Statement for the proposed business combination and be available at www.sec.gov. Additional information regarding the interests of such participants will be contained in the Registration Statement for the proposed business combination when available. Information about Mountain Crest’s directors and executive officers and their ownership of Mountain Crest common stock is set forth in Mountain Crest’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as modified or supplemented by any Form 3 or Form 4 filed with the SEC since the date of such filing. Other information regarding the interests of the participants in the proxy solicitation will be included in the Registration Statement pertaining to the proposed business combination when it becomes available. These documents can be obtained free of charge from the sources indicated above.

AUM and its directors and executive officers may also be deemed to be participants in the solicitation of proxies from the stockholders of Mountain Crest in connection with the proposed business combination. A list of the names of such directors and executive officers and information regarding their interests in the proposed business combination will be included in the Registration Statement for the proposed business combination.

Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Mountain Crest’s and AUM’s actual results may differ from their expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, Mountain Crest’s and AUM’s expectations with respect to future performance and anticipated financial impacts of the proposed business combination, the satisfaction of the closing conditions to the proposed business combination, and the timing of the completion of the proposed business combination.

These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside Mountain Crest’s and AUM’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the occurrence of any event, change, or other circumstances that could give rise to the termination of the Agreement; (2) the outcome of any legal proceedings that may be instituted against Mountain Crest and AUM following the announcement of the Agreement and the transactions contemplated therein; (3) the inability to complete the proposed business combination, including due to failure to obtain approval of the stockholders of Mountain Crest and AUM, certain regulatory approvals, or satisfy other conditions to closing in the Agreement; (4) the occurrence of any event, change, or other circumstance that could give rise to the termination of the Agreement or could otherwise cause the transaction to fail to close; (5) the impact of the COVID-19 pandemic on AUM’s business and/or the ability of the parties to complete the proposed business combination; (6) the inability to obtain the listing of Holdco’s ordinary shares on Nasdaq following the proposed business combination; (7) the risk that the proposed business combination disrupts current plans and operations as a result of the announcement and consummation of the proposed business combination; (8) the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition, the ability of AUM to grow and manage growth profitably, and retain its key employees; (9) costs related to the proposed business combination; (10) changes in applicable laws or regulations; (11) the possibility that Mountain Crest or AUM may be adversely affected by other economic, business, and/or competitive factors; (12) risks relating to the uncertainty of the projected financial information with respect to AUM; (13) risks related to the organic and inorganic growth of AUM’s business and the timing of expected business milestones, including but not limited to the safety and/or efficacy of AUM302, or AUM’s inability to obtain regulatory approval of any product; (14) the amount of redemption requests made by Mountain Crest’s stockholders; and (15) other risks and uncertainties indicated from time to time in the final prospectus of Mountain Crest for its initial public offering and the Registration Statement relating to the proposed business combination, including those under “Risk Factors” therein, and in Mountain Crest’s other filings with the SEC. Mountain Crest cautions that the foregoing list of factors is not exclusive. Mountain Crest and AUM caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Mountain Crest and AUM do not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in their expectations or any change in events, conditions, or circumstances on which any such statement is based.

For AUM Biosciences Pte. Ltd.:
Mr. Vishal Doshi
10 Anson Road, 24-16 A/B, Singapore, 079903

ICR Westwicke
Stephanie Carrington
T: (646) 277-1282

FINN Partners
Glenn Silver
T: (973) 818-8198

Verlynn Heng

GlobeNewswire Distribution I 8705763

ZeroBounce Launches India Website

Email validation and deliverability company ZeroBounce announces the launch of its India website. The site (zerobounce.in) processes customer data strictly within India, easing concerns about the country’s upcoming privacy laws.

ZeroBounce India

ZeroBounce India

SANTA BARBARA, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Email validation and deliverability company ZeroBounce announces the launch of its India website. The site (zerobounce.in) processes customer data strictly within India, easing concerns about the country’s upcoming privacy laws.

The new site is a result of user feedback and allows ZeroBounce’s customers the option to store and process all of their data solely within India. ZeroBounce hosts all of its related services in India, including the front and back-end website.

ZeroBounce.in goes live in the wake of India’s latest draft of the Digital Personal Data Protection (DPDP) Bill. First proposed in 2018, the bill aims to give individuals greater control over their data privacy. The DPDP Bill has had many iterations, including its withdrawal in August 2022. On Nov. 18, 2022, a new draft went up for public consultation and will be presented in Parliament next year.

“The DPDP Bill is neither final, nor the law, but its principles remain a potential concern for many companies in India,” explains ZeroBounce COO Brian Minick. “While we await guidance from a final bill, we created the new site and functionality to provide additional comfort for our existing and soon-to-be Indian clientele. ZeroBounce will continue to iterate on the site and functionality until there is a final bill.”

Furthermore, ZeroBounce employs military-grade data protection mechanisms. The company complies with GDPR protocols and has attained international security certifications such as SOC 2 Type 2, CCPA, and ISO 27001.

“The new site and functionality demonstrate our commitment to our Indian clients, and the steps we’re willing to take to ensure compliance with current and future local data privacy laws,” says ZeroBounce CEO Liviu Tanase.

Soon, ZeroBounce will also relaunch its platform Zerobounce.net, with an increased email validation accuracy of 99%, a more intuitive user experience, higher speeds, and better overall performance of its tools.

About ZeroBounce

ZeroBounce is an email verification and deliverability platform helping 200,000+ customers land more emails in the inbox.

The software removes email typos, nonexistent and abuse email accounts, spam traps, and other risky email addresses. ZeroBounce’s email deliverability toolkit further supports the safe inbox delivery of transactional and marketing emails. The company operates a military-grade security infrastructure. It is GDPR and SOC 2 Type 2 compliant and ensures the highest levels of data protection.

ZeroBounce has validated more than 13 billion emails. Some of the companies it serves are Amazon, Disney, Netflix, LinkedIn, Sephora, Lodha Group, and Tata Nexarc.

In 2022, ZeroBounce founded Email Day (April 23), now an international holiday honoring email inventor Ray Tomlinson.

For more information, visit https://www.zerobounce.net/ and https://zerobounce.in/.

Corina Leslie, +1-888-500-9521
PR Manager, office@zerobounce.net

Contact Information:
Corina Leslie
PR Manager

Related Images

Image 1: ZeroBounce India

ZeroBounce has just launched its website zerobounce.in

This content was issued through the press release distribution service at Newswire.com.


GlobeNewswire Distribution ID 8705349

Freshworks Welcomes Jason Loomis as Chief Information Security Officer

SAN MATEO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — Freshworks Inc. (NASDAQ: FRSH), a software company empowering the people who power business, today announced the appointment of Jason Loomis as Chief Information Security Officer. With this appointment, the company bolsters its senior technical leadership as it continues to put the power of software back in the people’s hands with applications easy enough for everyone to use.

“Businesses need fast, easy and secure software to delight their customers and employees,” said Prakash Ramamurthy, Chief Product Officer at Freshworks. “Jason brings a proven track record of operational excellence in security, at massive scale, to our team. We value the trust our customers place in Freshworks, and operating with a strong cybersecurity posture that can help mitigate data risk is of utmost importance.”

Jason brings more than 20 years of experience in information technology and cybersecurity leadership to the role, most recently serving as the Chief Information Security Officer at MINDBODY, Inc., overseeing an enterprise-wide information security program and leading a globally-dispersed team. Before that, he served as Chief Information Security Officer at TechStyle Fashion Group, the company behind brands including Fabletics and Savage X Fenty. He holds a Bachelor of Science in Management Information Systems from the University of San Francisco and a Master of Business Administration from the University of Oregon.

“Joining Freshworks was a natural choice for me. My fresh approach to cybersecurity perfectly aligns with how Freshworks has flipped the complex nature of software on its head to make solutions easy for anyone to use,” said Loomis. “I’m looking forward to working with the leadership team here at Freshworks to continue our evolution in being the provider of choice for security and reliability.”

About Freshworks
Freshworks Inc., (NASDAQ: FRSH) makes business software people love to use. Purpose-built for IT, customer support, and sales and marketing teams, our products empower the people who power business. Freshworks is fast to onboard, priced affordably, built to delight, yet powerful enough to deliver critical business outcomes. Headquartered in San Mateo, California, Freshworks operates around the world to serve more than 60,000 customers including Allbirds, Blue Nile, Bridgestone, Databricks, Klarna, NHS, OfficeMax, and PhonePe. For the freshest company news visit www.freshworks.com and follow us on Facebook, LinkedIn and Twitter.

© 2022 Freshworks Inc. All rights reserved. Freshworks, Freshservice and their associated logos are trademarks or registered trademarks of Freshworks Inc. All other company, brand and product names may be trademarks or registered trademarks of their respective companies.

Media Contact:
Erika Howard

GlobeNewswire Distribution ID 8705803

Bus accident killed Three, injured dozens in northern Thailand: local media

BANGKOK, A bus accident has killed at least three people and injured more than 40 others, in Thailand’s northern province of Tak, local media reported, today.


The bus was carrying migrant workers from Myanmar, to a factory in Thailand’s Songkhla province, when it crashed through the middle barrier of the road, and plunged into the roadside ditch, last night, according to the Thai national daily, Matichon.


The injured have been rushed to a local hospital, and the cause of the accident was still under investigation.


Source: Nam News Network

Thailand has its first case of Deltacron, patient has recovered

The Thai Medical Sciences Department has detected the country’s first infection of the COVID-19 Omicron XBC variant, or Deltacron. The patient has, however, already recovered from the disease, said Dr. Supakit Sirilak, the department’s director-general, today (Wednesday).


According to GISAID, as of November 20th, 153 XBC cases have been recorded worldwide, but there have been no clear signs that the variant, which is a recombinant between the Delta variant and the BA.2 sub-lineage of Omicron, is more severe than the other COVID-19 variants or sub-variants.


Dr. Supakit said that, between November 19th and 25th, the Medical Sciences Department monitored 299 cases and discovered that Omicron BA.2.75 variant infections have increased 63.3% from the previous week, with most of the cases being locally acquired infections.


He disclosed that the department had found more than 468 cases of BA.2.75 variant infection and its sub-variants, such as BA.2.75.2, BA.2.75.51 and BA., while cases of BN.1 variant and it sub-variant infections have increased fourfold from the previous week.


According to the worldwide situation weekly report, the Omicron BA.5 variant and its sub-variants account for 72.1%of all new infections. BQ.1 variant and its sub-variant cases have increased by 23.1% from the previous week.


Dr. Taweesin Visanuyothin, deputy permanent secretary of public health, meanwhile, said that COVID-19 infections arelikely to increase during the cold season, as he urged people,who had their most recent vaccination more than four months ago, to get a booster to increase their immunity.


Source: Thai Public Broadcasting Service